About LifeAssays

A Great Product Always Make Friends LifeAssays® is a Swedish diagnostic company focused on providing accurate and affordable point-of-care diagnostic testing for veterinarians, community health centres and primary physicians based on our unique, patented point-of-care technology platform. LifeAssays® AB was founded in 2000. The technology was developed at Lund University, Sweden, and is based on small, nano-size magnetic particles and their subsequent application in biotechnological and medical research. The unique, patented point-of-care technology is composed of nano-size magnetic particles and a detector system for the identification of biological markers utilizing the technology. This point-of- care platform is the foundation of the diagnostic company LifeAssays®. Today LifeAssays® is a growing diagnostic company with in-house development, manufacturing and market & sales. The company has been listed on the Nordic Growth Market stock exchange in Stockholm, Sweden since 2002. November 2015, Lifeassays aquired the Magnasense company in Finland. LifeAssays and Magnasense offer 2 different nano particle based immunoassays platforms for interested parties who are looking for a reliable easy and highly accurate technology platform . It is real point of care and as sensitive as an Elisa but without any interference.

Facts about LifeAssays
  • Focus : Manufacturer
  • Industry : Diagnostics

Product portfolio of LifeAssays

Product portfolio

Here you will find LifeAssays AB

See the theme worlds for related content

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

10+ products
4 whitepaper
10+ brochures
View topic world

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

10+ products
4 whitepaper
10+ brochures